MYH9 and non-small cell lung carcinoma: The overall survival time of patients with up-regulated MYH9 expression (43 months) was significantly shorter than that of patients with low expression of MYH9 (72 months) (Fig. 6C), indicating that MYH9 can predict the survival time of patients with NSCLC.